Showing results (191-200 of 1,072) with videos related to

Sort By:
Pageof 108
Progress in Cardiovascular Diseases|January 2, 2018
Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet TherapyJae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 2, 2017
Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to BedsideJae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Thrombosis and Haemostasis|June 29, 2020
Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the EvidenceJeffrey Ian Weitz, Dominick J Angiolillo, Tobias Geisler, et al.
European Heart Journal|September 21, 2022
The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertaintiesJurrien Ten Berg, Bianca Rocca, Dominick J Angiolillo, et al.
Therapeutic Advances in Cardiovascular Disease|July 3, 2013
Update on platelet glycoprotein IIb/IIIa inhibitors: recommendations for clinical practiceAna Muñiz-Lozano, Fabiana Rollini, Francesco Franchi, et al.
Expert Review of Hematology|November 2, 2017
The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shiftsJae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
European Heart Journal|July 11, 2025
Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysisGiovanni Occhipinti, Claudio Laudani, Mattia Galli, et al.
JACC. Cardiovascular Interventions|February 11, 2022
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary SyndromesClaudio Laudani, Antonio Greco, Giovanni Occhipinti, et al.
The American Journal of Cardiology|January 8, 2011
Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantationRoberta Rossini, Davide Capodanno, Corrado Lettieri, et al.
Journal of Thrombosis and Thrombolysis|November 28, 2012
Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigationJosé L Ferreiro, Masafumi Ueno, Antonio Tello-Montoliu, et al.
Pageof 108